Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea · Delayed Price · Currency is KRW 25,400
-1,900 (-6.96%)
Sep 22, 2026, 3:30 PM KST
Orum Therapeutics Market Cap
Orum Therapeutics has a market cap or net worth of 592.94 billion as of September 22, 2026. Its market cap has decreased by -21.83% in one year.
Market Cap
592.94B
Enterprise Value
437.24B
Revenue
40.55M
Ranking
n/a
PE Ratio
32.03
Stock Price
25,400.00
ChartMarket Cap Chart
Since February 14, 2025, Orum Therapeutics's market cap has increased from 456.25B to 592.94B, an increase of 29.96%. That is a compound annual growth rate of 17.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 592.94B | -76.73% |
| Dec 30, 2025 | 2.55T | 458.43% |
| Feb 14, 2025 | 456.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Pharmicell | 751.85B |
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |